Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 3
2009 3
2010 6
2011 10
2012 7
2013 4
2014 7
2015 6
2016 4
2017 1
2018 7
2019 1
2020 1
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Immunogenicity of Protein Pharmaceuticals.
Dingman R, Balu-Iyer SV. Dingman R, et al. Among authors: balu iyer sv. J Pharm Sci. 2019 May;108(5):1637-1654. doi: 10.1016/j.xphs.2018.12.014. Epub 2018 Dec 30. J Pharm Sci. 2019. PMID: 30599169 Free PMC article. Review.
Delivery of therapeutic proteins.
Pisal DS, Kosloski MP, Balu-Iyer SV. Pisal DS, et al. Among authors: balu iyer sv. J Pharm Sci. 2010 Jun;99(6):2557-75. doi: 10.1002/jps.22054. J Pharm Sci. 2010. PMID: 20049941 Free PMC article. Review.
Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines.
Hofman K, Shenoy GN, Chak V, Balu-Iyer SV. Hofman K, et al. Among authors: balu iyer sv. Immunol Invest. 2021 Oct;50(7):743-779. doi: 10.1080/08820139.2021.1904977. Epub 2021 Apr 30. Immunol Invest. 2021. PMID: 33929280 Free PMC article. Review.
Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments.
Bhatta M, Shenoy GN, Loyall JL, Gray BD, Bapardekar M, Conway A, Minderman H, Kelleher RJ Jr, Carreno BM, Linette G, Shultz LD, Odunsi K, Balu-Iyer SV, Pak KY, Bankert RB. Bhatta M, et al. Among authors: balu iyer sv. J Immunother Cancer. 2021 Oct;9(10):e003148. doi: 10.1136/jitc-2021-003148. J Immunother Cancer. 2021. PMID: 34599030 Free PMC article.
55 results